Sheldon Inwentash

Chairman and CEO - Mega Uranium

Sheldon Inwentash is responsible for the overall strategic vision and direction for the Company. Mr. Inwentash and his management team have built Mega Uranium into one of the fastest growing junior mining companies globally, by identifying and acquiring quality uranium properties. Mr. Inwentash brings more than 20 years of experience in the investment industry and a deep understanding of progressive investment and financial management strategies. He is currently an Ontario finalist for the 2007 Ernst & Young Entrepreneur Of The Year Award. A Chartered Accountant, Mr. Inwentash is also the Chairman and CEO of Pinetree Capital Ltd., a Canadian investment company with a portfolio of investments primarily in the resource and energy sectors.

In 1992, Pinetree was founded by Sheldon Inwentash to be a venture investor in early stage, emerging technology companies. It was initially capitalized with approximately $4 million in order to acquire a 30% stake in a Montreal-based biotechnology company called BioSignal Inc. which was subsequently acquired by Perkin Elmer.

In 1994, Mr. Inwentash founded Genevest Inc. to be a venture investor in early stage, emerging biotechnology companies. Its initial capitalization was also about $4 million, and that money was used to start Visible Genetics Inc. (“VGI”). VGI was the world’s first company specializing in pharmacogenomics, went public on NASDAQ in 1996, had a peak market value of over US$1 billion and was eventually sold to Bayer. Genevest’s profits on this investment totaled over $35 million.

From the mid-1990s to 2004, Pinetree specialized in early stage technology investing while Genevest focused on early stage biotechnology investing. Both companies thrived in these arenas, which require a long term view and excellent vision.

In 2001, both companies emerged intact and strong after the bursting of the tech bubble.